๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

โœ Scribed by Alison Grann; Bruce D. Minsky; Alfred M. Cohen; Leonard Saltz; Jose G. Guillem; Philip B. Paty; David P. Kelsen; Nancy Kemeny; David Ilson; Joanne Bass-Loeb

Publisher
Springer
Year
1997
Tongue
English
Weight
739 KB
Volume
40
Category
Article
ISSN
0012-3706

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Preoperative high-dose leucovorin/5-fluo
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer
โœ Bruce D. Minsky; Nancy Kemeny; David P. Kelsen; Bonnie Reichman; Leonard Saltz; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 732 KB

Twenty patients with primary or recurrent unresectable rectal cancer limited to the pelvis were entered on a Phase I trial of preoperative pelvic radiation therapy (RT) (5040 cGy) and two cycles of combined high-dose leucovorin (LV) and 5fluorouracil (S-FU), followed by surgery and ten cycles of pos

The efficacy of preoperative 5-fluoroura
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer
โœ Bruce D. Minsky; Joanne Frankel; Alfred M. Cohen; Warren E. Enker; Nancy Kemeny; ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 744 KB

Background. The encouraging results seen in patients who received postoperative combined modality therapy in the adjuvant setting have prompted increased interest in preoperative combined modality therapy for patients with unresectable rectal cancer. The authors report the local control and survival